WORLD JOURNAL OF ADVANCE
HEALTHCARE RESEARCH

( An ISO 9001:2015 Certified International Journal )

An International Peer Review Journal for Medical Science and Pharma Professionals

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

World Journal of Advance Healthcare Research (WJAHR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , Cosmos Impact Factor , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , Scientific Journal Impact Factor (SJIF) , IFSIJ Measure of Journal Quality , International Scientific Indexing, UAE (ISI) (Under Process) , International Impact Factor Services (IIFS) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Academia , Scope Database , Research Publication Rating and Indexing , Doi-Digital Online Identifier , ISSN National Centre , Zenodo Indexing , International CODEN Service, USA , 

ISSN 2457-0400

Impact Factor  :  6.711

WJAHR Citation

  All Since 2020
 Citation  105  60
 h-index  4  4
 i10-index  3  2

News & Updation

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in WJAHR coming Issue.

  • WJAHR: New Impact Factor

    WJAHR Impact Factor has been Increased to 6.711 for Year 2024.

  • WJAHR: DECEMBER ISSUE PUBLISHED

    DECEMBER 2025 Issue has been successfully launched on DECEMBER 2025.

  • New Issue Published

    Its Our pleasure to inform you that, WJAHR December 2025 Issue has been Published, Kindly check it on https://www.wjahr.com/home/current_issues

Best Article Awards

World Journal of Advance Healthcare Research (WJAHR) is giving Best Article Award in every Issue for Best Article and Issue Certificate of Appreciation to the Authors to promote research activity of scholar.

Best Article of current issue

Download Article : Click here

Indexing

Abstract

LEFT VENTRICULAR HYPERTROPHY REGRESSION AFTER OPTIMAL BLOOD PRESSURE CONTROL IN HYPERTENSIVE PATIENTS

*Abdulhadi Mohammed Tarkh, Amer Ahmed Abdullah Al-Qaftan, Duraid Khalil Ibrahim

ABSTRACT

Background: Hypertension (HT) is a critical risk factor for the development of cardiovascular disease and a major public health concern. There are still a number of unclear issues about antihypertensive medication and LVH regression; one of the most important clinical questions is whether LVH is reversible or not. Objectives: To assess the factors associated with left ventricular hypertrophy among patients with optimum controlled hypertension. Methods: This is a cross-sectional study. Included adult patients aged more than 18 years old who had hypertension based on a history of prior diagnosis and therapy, blood pressure ≥ 140/90 mmHg on two to three office visits two weeks apart, home blood pressure readings >130/80 mmHg, or a single blood pressure reading of ≥180/110 mmHg. The study patients were assessed at the medical consultation clinic of Al-Shirqat General Hospital from August 2022 to October 2025. The questionnaire consisted from four sections. Section one for sociodemographic and anthropometric measurements, section two for baseline and follow up systolic, diastolic and heart rate measurements, section three for different clinical and biochemical variables and section four for Echocardiographic findings of the patients. Results: The study included 400 patients; 50 (12.5%) patients had left ventricular regression and 350 (87.5%) patients with no left ventricular regression. The mean age ± standard deviation of the study participants was 59.25 ± 10.72 years. Statistically significant difference between the two groups regarding their gender, smoking state, presence of obesity, mean of ages and mean of BMI (P value <0.05). In addition to that, statistically significant difference between the two groups with regard to their baseline and follow up means of systolic, diastolic blood pressure (P value <0.05) for all of them. Moreover, statistically significant difference between the two groups with regard to the presence of diabetes (P value = 0.019), and mean of estimated glomerular filtration rate (P value = 0.046). Conclusion: Certain factors significantly associated with decrease the possibility of LVH regression. These factors are female gender, elderly, smoking, obesity, higher systolic and diastolic blood pressure with prolonged duration, presence of diabetes and lower estimated glomerular filtration rate. Clinician should treat hypertensive patients as soon as possible with special attention to the presence of these factors.

[Full Text Article] [Download Certificate]